# Fidelity D & D Bancorp Inc: financial statements, quarterly

FDBC · Nasdaq · CIK 1098151 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fdbc.md) · [Financials](/companies/fdbc/financials.md) · [Filings](/companies/fdbc/filings.md) · [Insiders](/companies/fdbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fdbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [9.0](/filings/0001437749-23-031654.md) | [9.9 d](/filings/0001437749-24-008680.md) | [10.7](/filings/0001437749-24-016685.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.6](/filings/0001437749-24-034533.md) | [(0.4) d](/filings/0001437749-25-007555.md) | [0.7](/filings/0001437749-25-015781.md) | [0.8](/filings/0001437749-25-025716.md) | [0.8](/filings/0001437749-25-033855.md) | [0.8 d](/filings/0001437749-26-008215.md) | [1.1](/filings/0001437749-26-015900.md) | [1.3](/filings/0001437749-26-026575.md) | [1.2](/filings/0001437749-25-033855.md) | [1.3 d](/filings/0001437749-26-008215.md) | [1.0](/filings/0001437749-26-015900.md) | [1.7](/filings/0001437749-26-026575.md) |
| Net income | $m | [5.3](/filings/0001437749-24-034533.md) | [0.5 d](/filings/0001437749-25-007555.md) | [5.1](/filings/0001437749-25-015781.md) | [4.9](/filings/0001437749-25-025716.md) | [5.0](/filings/0001437749-25-033855.md) | [5.8 d](/filings/0001437749-26-008215.md) | [6.0](/filings/0001437749-26-015900.md) | [6.9](/filings/0001437749-26-026575.md) | [7.3](/filings/0001437749-25-033855.md) | [7.9 d](/filings/0001437749-26-008215.md) | [7.5](/filings/0001437749-26-015900.md) | [7.8](/filings/0001437749-26-026575.md) |
| Diluted EPS | $ per share | [0.93](/filings/0001437749-24-034533.md) | not reported | [0.88](/filings/0001437749-25-015781.md) | [0.86](/filings/0001437749-25-025716.md) | [0.86](/filings/0001437749-25-033855.md) | not reported | [1.03](/filings/0001437749-26-015900.md) | [1.20](/filings/0001437749-26-026575.md) | [1.27](/filings/0001437749-25-033855.md) | not reported | [1.28](/filings/0001437749-26-015900.md) | [1.33](/filings/0001437749-26-026575.md) |
| Basic EPS | $ per share | [0.94](/filings/0001437749-24-034533.md) | not reported | [0.88](/filings/0001437749-25-015781.md) | [0.86](/filings/0001437749-25-025716.md) | [0.87](/filings/0001437749-25-033855.md) | not reported | [1.04](/filings/0001437749-26-015900.md) | [1.20](/filings/0001437749-26-026575.md) | [1.27](/filings/0001437749-25-033855.md) | not reported | [1.29](/filings/0001437749-26-015900.md) | [1.34](/filings/0001437749-26-026575.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [110](/filings/0001437749-23-031654.md) | [112](/filings/0001437749-25-007555.md) | [72.7](/filings/0001437749-24-016685.md) | [78.1](/filings/0001437749-24-026070.md) | [120](/filings/0001437749-24-034533.md) | [83.4](/filings/0001437749-26-008215.md) | [211](/filings/0001437749-25-015781.md) | [165](/filings/0001437749-25-025716.md) | [142](/filings/0001437749-25-033855.md) | [148](/filings/0001437749-26-026575.md) | [155](/filings/0001437749-26-015900.md) | [208](/filings/0001437749-26-026575.md) |
| Total assets | $m | [2,477](/filings/0001437749-23-031654.md) | [2,503](/filings/0001437749-25-007555.md) | [2,469](/filings/0001437749-24-016685.md) | [2,501](/filings/0001437749-24-026070.md) | [2,616](/filings/0001437749-24-034533.md) | [2,585](/filings/0001437749-26-008215.md) | [2,711](/filings/0001437749-25-015781.md) | [2,699](/filings/0001437749-25-025716.md) | [2,737](/filings/0001437749-25-033855.md) | [2,748](/filings/0001437749-26-026575.md) | [2,859](/filings/0001437749-26-015900.md) | [2,971](/filings/0001437749-26-026575.md) |
| Total liabilities | $m | [2,311](/filings/0001437749-23-031654.md) | [2,314](/filings/0001437749-25-007555.md) | [2,277](/filings/0001437749-24-016685.md) | [2,305](/filings/0001437749-24-026070.md) | [2,409](/filings/0001437749-24-034533.md) | [2,381](/filings/0001437749-26-008215.md) | [2,500](/filings/0001437749-25-015781.md) | [2,481](/filings/0001437749-25-025716.md) | [2,508](/filings/0001437749-25-033855.md) | [2,509](/filings/0001437749-26-026575.md) | [2,615](/filings/0001437749-26-015900.md) | [2,718](/filings/0001437749-26-026575.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [124](/filings/0001437749-23-031654.md) | [117](/filings/0001437749-25-007555.md) | [25.0](/filings/0001437749-24-016685.md) | [98.1](/filings/0001437749-24-026070.md) | [25.0](/filings/0001437749-24-034533.md) | [0.0](/filings/0001437749-26-008215.md) | [0.0](/filings/0001437749-25-015781.md) | [0.0](/filings/0001437749-25-025716.md) | [0.0](/filings/0001437749-25-033855.md) | [0.0](/filings/0001437749-26-026575.md) | [0.0](/filings/0001437749-26-015900.md) | [120](/filings/0001437749-26-026575.md) |
| Shareholders' equity | $m | [165](/filings/0001437749-24-034533.md) | [189](/filings/0001437749-26-008215.md) | [192](/filings/0001437749-25-025716.md) | [196](/filings/0001437749-25-033855.md) | [207](/filings/0001437749-25-033855.md) | [204](/filings/0001437749-26-026575.md) | [212](/filings/0001437749-26-026575.md) | [218](/filings/0001437749-26-026575.md) | [229](/filings/0001437749-25-033855.md) | [239](/filings/0001437749-26-026575.md) | [245](/filings/0001437749-26-026575.md) | [253](/filings/0001437749-26-026575.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.3 d](/filings/0001437749-24-034533.md) | [8.3 d](/filings/0001437749-25-007555.md) | [5.3](/filings/0001437749-25-015781.md) | [8.7 d](/filings/0001437749-25-025716.md) | [9.1 d](/filings/0001437749-25-033855.md) | [6.5 d](/filings/0001437749-26-008215.md) | [11.7](/filings/0001437749-26-015900.md) | [12.6 d](/filings/0001437749-26-026575.md) | [8.4 d](/filings/0001437749-25-033855.md) | [9.7 d](/filings/0001437749-26-008215.md) | [7.6](/filings/0001437749-26-015900.md) | [20.5 d](/filings/0001437749-26-026575.md) |
| Capital expenditure | $m | [2.0 d](/filings/0001437749-24-034533.md) | [2.4 d](/filings/0001437749-25-007555.md) | [1.3](/filings/0001437749-25-015781.md) | [1.5 d](/filings/0001437749-25-025716.md) | [1.3 d](/filings/0001437749-25-033855.md) | [0.6 d](/filings/0001437749-26-008215.md) | [0.2](/filings/0001437749-26-015900.md) | [5.7 d](/filings/0001437749-26-026575.md) | [6.2 d](/filings/0001437749-25-033855.md) | [5.4 d](/filings/0001437749-26-008215.md) | [4.3](/filings/0001437749-26-015900.md) | [3.4 d](/filings/0001437749-26-026575.md) |
| Dividends paid | $m | [1.7 d](/filings/0001437749-24-034533.md) | [1.8 d](/filings/0001437749-25-007555.md) | [2.1](/filings/0001437749-25-015781.md) | [2.2 d](/filings/0001437749-25-025716.md) | [2.2 d](/filings/0001437749-25-033855.md) | [2.3 d](/filings/0001437749-26-008215.md) | [2.3](/filings/0001437749-26-015900.md) | [2.3 d](/filings/0001437749-26-026575.md) | [2.3 d](/filings/0001437749-25-033855.md) | [2.4 d](/filings/0001437749-26-008215.md) | [2.5](/filings/0001437749-26-015900.md) | [2.4 d](/filings/0001437749-26-026575.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-23-031654.md) | [0.0 d](/filings/0001437749-24-008680.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,686](/filings/0001437749-23-023337.md) | [5,666](/filings/0001437749-23-031654.md) | [5,692](/filings/0001437749-24-016685.md) | [5,704](/filings/0001437749-24-026070.md) | [5,725](/filings/0001437749-24-034533.md) | [5,762](/filings/0001437749-25-015781.md) | [5,766](/filings/0001437749-25-025716.md) | [5,777](/filings/0001437749-25-033855.md) | [5,789](/filings/0001437749-26-015900.md) | [5,791](/filings/0001437749-26-026575.md) | [5,819](/filings/0001437749-26-015900.md) | [5,891](/filings/0001437749-26-026575.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,808,508 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026575.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.